Fig. 1
From: Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
Study demographics and ATN biomarker profiles at baseline and follow-up. The analyses included 262 non-demented elderly individuals, with baseline and follow-up data of CSF Aβ42, p-tau, and FDG-PET metabolism, with seven different ATN biomarker profiles based on ATN classification. During the follow-up period of 6 to 120 months, the detailed process of the changes in ATN biomarker profiles in these individuals from the ADNI cohort was shown